Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoembolization of Uveal Melanoma Hepatic Metastases Using 300mg of BCNU Dissolved in Lipiodol® Followed by Gelfoam® Embolization

NCT04728633 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT04728633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoembolization of Uveal Melanoma Hepatic Metastases Using 300mg of BCNU Dissolved in Lipiodol® Followed by Gelfoam® Embolization
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 27, 2021
Completion date
June 30, 2027
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the liver, metastatic uveal melanoma, stage iv choroidal and ciliary body melanoma ajcc v8